Price movement over the last 24 hours
Asri Karya Lestari Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Asri Karya Lestari Tbk. trades at Rp200 (market cap 1.29T, 1.73M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: Asri Karya Lestari Tbk. is far larger — about 2.3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 1.73M). Which is the better fit depends on your goals.
| ASLI | LABS | |
|---|---|---|
Market Cap | 1.29T | 556.95B |
Volume | 1.73M | 60.83M |
Lot | 17.29K | 608.34K |
Turnover | 349.74M | 10.26B |
Average Price | 202.26 | 168.64 |
Value | 349.74M | 10.26B |
Indicative Equilibrium Price | 200 | 152 |
Indicative Equilibrium Volume | 1.01K | 4.52K |
Trailing returns across standard periods
Latest headlines on both assets
PT Asri Karya Lestari Tbk (‘the Entity’) was established as a limited liability company based on deed No. 05 on December 20, 2008 before Notary Syanti Hardiyanti, SH in Jakarta. The entity started its commercial operations in 2009
Read more on ASLI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →